Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 45Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 3Neoplasms 2Sexual Dysfunction, Physiological 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Eunuchism 1Erectile Dysfunction 1Delirium 1Agnosia 1

Interventions

Microarray Analysis 2Immunoenzyme Techniques 2Data Collection 2Vascular Endothelial Growth Factor A 1Tomography, Optical Coherence 1Tissue Banks 1Polymerase Chain Reaction 1Pemetrexed 1Mitoxantrone 1Hyperthermic Intraperitoneal Chemotherapy 1Gene Expression Profiling 1Flow Cytometry 1Drug Therapy 1Blood Specimen Collection 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Mesothelioma, Malignant × Pemetrexed × Clear all
NCT04843007 2024-10-23

Alvopem® (Pemetrexed) Safety Assessment

NanoAlvand

Completed
199 enrolled 21 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡